Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-10-001855
Filing Date
2010-03-31
Accepted
2010-03-31 17:22:52
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ORE PHARMACEUTICAL HOLDINGS INC. 10-K a6229817.htm 10-K 1035655
2 EXHIBIT 10.30 a6229817ex10-30.htm EX-10.30 51843
3 EXHIBIT 21 a6229817ex21.htm EX-21 1060
4 EXHIBIT 23 a6229817ex23.htm EX-23 4844
5 EXHIBIT 31.1 a6229817ex31-1.htm EX-31.1 10639
6 EXHIBIT 31.2 a6229817ex31-2.htm EX-31.2 10770
7 EXHIBIT 32 a6229817ex32.htm EX-32 11212
  Complete submission text file 0001157523-10-001855.txt   1127711
Mailing Address ONE MAIN STREET SUITE 300 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 300 CAMBRIDGE MA 02142 6176492001
ORE PHARMACEUTICAL HOLDINGS INC. (Filer) CIK: 0001043914 (see all company filings)

EIN.: 061411336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23317 | Film No.: 10720533
SIC: 2835 In Vitro & In Vivo Diagnostic Substances